NL7112083A - - Google Patents

Info

Publication number
NL7112083A
NL7112083A NL7112083A NL7112083A NL7112083A NL 7112083 A NL7112083 A NL 7112083A NL 7112083 A NL7112083 A NL 7112083A NL 7112083 A NL7112083 A NL 7112083A NL 7112083 A NL7112083 A NL 7112083A
Authority
NL
Netherlands
Application number
NL7112083A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7112083A publication Critical patent/NL7112083A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/006Coating of the granules without description of the process or the device by which the granules are obtained

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NL7112083A 1970-09-16 1971-09-02 NL7112083A (US07754267-20100713-C00021.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7285670A 1970-09-16 1970-09-16

Publications (1)

Publication Number Publication Date
NL7112083A true NL7112083A (US07754267-20100713-C00021.png) 1972-03-20

Family

ID=22110165

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7112083A NL7112083A (US07754267-20100713-C00021.png) 1970-09-16 1971-09-02

Country Status (4)

Country Link
AU (1) AU3317871A (US07754267-20100713-C00021.png)
DE (1) DE2146174A1 (US07754267-20100713-C00021.png)
FR (1) FR2106566A1 (US07754267-20100713-C00021.png)
NL (1) NL7112083A (US07754267-20100713-C00021.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
DE2347713C3 (de) * 1972-09-25 1980-03-06 Warner-Lambert Co., Morris Plains, N.J. (V.St.A.) Acetylsalicylsäurekautablette
ZA739543B (en) * 1973-02-16 1975-03-26 Hoffmann La Roche Free-flowing, directly tablettable, pharmaceutically active substances
GB1479655A (en) * 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
US4173626A (en) 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
GB2075458B (en) * 1980-04-21 1983-06-02 Nicholas Pty Ltd Encapsulation of indomethacin
DE4119306C2 (de) * 1991-06-12 1996-05-30 Wheli Inter Ag Organische Rohstoffe, Zwischen- und Endprodukte für die Ernährung und zur Verwendung für technische Zwecke, die Vitalstoffe enthalten
IE940292A1 (en) * 1994-04-06 1995-10-18 Elan Corp Plc Biodegradable microcapsules and method for their manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
FR5788M (US07754267-20100713-C00021.png) * 1965-11-18 1968-03-18
US3557279A (en) * 1969-06-12 1971-01-19 Merck & Co Inc Microencapsulation form of an anti-inflammatory drug

Also Published As

Publication number Publication date
FR2106566A1 (en) 1972-05-05
AU3317871A (en) 1973-03-15
DE2146174A1 (de) 1972-03-30
FR2106566B1 (US07754267-20100713-C00021.png) 1975-04-18

Similar Documents

Publication Publication Date Title
AR204384A1 (US07754267-20100713-C00021.png)
FR2106566B1 (US07754267-20100713-C00021.png)
ATA96471A (US07754267-20100713-C00021.png)
AU1473870A (US07754267-20100713-C00021.png)
AU1146470A (US07754267-20100713-C00021.png)
AU2044470A (US07754267-20100713-C00021.png)
AU2085370A (US07754267-20100713-C00021.png)
AU1716970A (US07754267-20100713-C00021.png)
AU1336970A (US07754267-20100713-C00021.png)
AU1833270A (US07754267-20100713-C00021.png)
AU1517670A (US07754267-20100713-C00021.png)
AU1326870A (US07754267-20100713-C00021.png)
AR195465A1 (US07754267-20100713-C00021.png)
AU1789870A (US07754267-20100713-C00021.png)
AU1581370A (US07754267-20100713-C00021.png)
AU1004470A (US07754267-20100713-C00021.png)
AU2061170A (US07754267-20100713-C00021.png)
AU1591370A (US07754267-20100713-C00021.png)
AU1603270A (US07754267-20100713-C00021.png)
AU1083170A (US07754267-20100713-C00021.png)
AU1689770A (US07754267-20100713-C00021.png)
AU1086670A (US07754267-20100713-C00021.png)
AU2130770A (US07754267-20100713-C00021.png)
ATA672271A (US07754267-20100713-C00021.png)
AU1343870A (US07754267-20100713-C00021.png)